TTrialPathMatch Me to Trials
← Back to trials
RecruitingUnipolar Depression

Transcranial Direct Current Stimulation for Depression

Eligible age

22+ yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

This study will test the efficacy of transcranial direct current stimulation (tDCS) combined with mindfulness, remotely-delivered using a telemedicine protocol in 25 adults with unipolar depression.

Sponsor: Soterix Medical

You may qualify if…

  • ✓ Clinically stable patients that meet criteria for diagnosis of MDD according to DSM-V-TR and confirmed with the Mini International Neuropsychiatric interview
  • ✓ Currently experiencing a major depressive episode of at least 4 week's duration as part of a unipolar depression
  • ✓ QIDS-SR score \>11 on all three days of screening week (Days 1,3, 7)
  • ✓ Scored at least 17 (inclusive) on the HDRS-17 at trial entry
  • ✓ Any antidepressant medication is stable ≥ 30 days prior to HDRS-17 screening
  • ✓ Female patients are allowed if not pregnant and using a medically acceptable method of contraception, if of childbearing potential.

You may not qualify if…

  • ✕ Failure to respond to at least 2 antidepressant medications
  • ✕ Drug or alcohol abuse or dependence in the preceding 3 months
  • ✕ Concurrent benzodiazepine medication
  • ✕ High suicide risk assessed during clinician screening at baseline interview.
  • ✕ Failure to respond to ECT treatment or rTMS treatment in this or any previous episode.
  • ✕ Current DSM-V-TR psychotic disorder
  • ✕ History of clinically defined neurological disorder or insult that may impact participation in this study as determined by study physician
  • ✕ Metal in the cranium or skull defects

Where it's recruiting

New Jersey

Woodbridge

Source: ClinicalTrials.gov · NCT07042217 · last updated 2025-11-10

Transcranial Direct Current Stimulation for Depression · TrialPath